Prospective triAl of Modified Treat-and-extend Regimens With BroLucizumab in pachychOroid Neovasculopathy
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cluster Randomized Trial of a Digital Quality Improvement Intervention on LDLCholesterol Control
- Status
- COMPLETED
- Phase
- NA
Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers
- Status
- WITHDRAWN
- Phase
- PHASE2
Central Nervous System Efficacy of Capmatinib in NSCLC With Brain Metastases With cfDNA Positive MET Alterations
- Status
- WITHDRAWN
- Phase
- PHASE2
A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Retrospective Epidemiologic Registry to Gain Insight Into the Characteristics and Prognosis of AML Patients According to the Routinely Used Genetic and Biologic Markers
- Status
- COMPLETED
- Phase
- N/A
Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma
- Status
- RECRUITING
- Phase
- PHASE2
PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Value Based Healthcare in Psoriasis
- Status
- RECRUITING
- Phase
- NA
LITMUS Imaging Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
- Status
- RECRUITING
- Phase
- N/A
Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Crizanlizumab Improves Tissue Oxygen Supply Demand Matching in Patients With Sickle Cell Anemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation
- Status
- TERMINATED
- Phase
- PHASE1
Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study
- Status
- COMPLETED
- Phase
- N/A
FOLFIRINOX + NIS793 in Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Asciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
"Association of Proteinuria and Progression of Kidney Dysfunction in Sickle Cell Disease"Disease
- Status
- COMPLETED
- Phase
- N/A